skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

99+ Total results for product and free and sample content found

Skipta

Pharma Marketing: How to succeed in the era of declining budgets

Pharma Marketing: How to succeed in the era of declining budgets

Discover how others in pharma are coping with reduced budgets and the pressure to hit the right healthcare professional (HCP) targets in this data-packed infographic from Skipta.  

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Trialtrove:...

COVID-19 Infographic

COVID-19 Infographic

Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.

Topic Coronavirus

Biomedtracker: 開発中医薬品をFDA承認確率で評価

Biomedtracker Potential Pivots in 2020

Biomedtracker Potential Pivots in 2020

In this infographic, we provide insight into key trials that are expecting developments in the approval process.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Buyers and Sellers: How Corporate Transactions are Shaping the Big Pharma Landscape

Buyers and Sellers: How Corporate Transactions are Shaping the Big Pharma Landscape

Scrip has been scrutinizing significant M&A deals in the pharma industry in light of companies’ 2019 financial results. We bring you insights into the impact of major acquisitions and divestments by Big Pharma, and consider what it means for the future. 

awareness

Powering Pharma and Medtech To Make Effective Clinical Regulatory and Commercial Decisions

Powering Pharma and Medtech To Make Effective Clinical Regulatory and Commercial Decisions

With deep Pharma industry and marketing expertise, we can help you to reach Pharma’s elusive decision makers with relevant high-impact and engaging content, so you can reach your business and revenue objectives.  

Skipta

The Changing Landscape of Pharma Marketing

The Changing Landscape of Pharma Marketing

Understanding the intricacies of pharma marketing can be tough, but Skipta has you covered. A leading social network of specialized online medical communities for over 700,000 verified healthcare professionals, Skipta can pinpoint and connect you to your exact targets – quickly and easily.

Adoptive Cell Therapy

Adoptive Cell Therapy

Citeline recently introduced a new Therapeutic Class called "Adoptive cell therapy", enabling more granular searching capabilities to hone in on this exciting cancer immunotherapy that is expanding the horizon of personalized medicine

Topic cell-and-gene-therapy

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Cardiovascular Disease Epidemiology Overview

Cardiovascular Diseases (CVDs) are one of the leading causes of disease burden worldwide. This epidemiology overview presents the prevalence of some CVDs and their associated clinical risk factors analyzed by Datamonitor Healthcare.

Skipta: Digital Clutter Infographic

Explore the challenges in digital marketing that can make it difficult for you to directly connect with your specific target audience. Let Skipta’s exclusive perspectives be your guide.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。